![](https://investorshub.advfn.com/uicon/522650.png?cb=1464431304)
Sunday, June 28, 2015 9:26:25 AM
As opioids become harder to abuse, heroin use (and heroin deaths) increases. Unfortunately, heroin is as pure and as cheap as it ever has been. Fortunately, that problem is not for Elite to solve.
Obviously the question of what makes ELTP a good investment is different from why bother with ADF if abusers will simply turn to street heroin. The good vs. bad investment question is what gets argued here daily, so I'll address the other question, from a medical perspective.
As physicians, we have more high-quality tools to treat chronic pain than ever before. From a diagnostic perspective, we can map out an exact mechanical source of pain with high-quality imaging, such as MRI. We can determine specific nerve involvement with EMG. We can address some types of pain with procedures such as epidurals, nerve blocks, and intra-articular injections. Orthopedic and neurosurgical procedures have become precise in their targets, which minimizes potential complications. Non-opioid medications for chronic pain are better than ever- Cymbalta, Neurontin, Lyrica, even SSRI's like Lexapro are proven safe and effective.
But the simple fact is that non-opioid options for pain management are not effective or have limited effectiveness for some patients. And opioids work. They must be used responsibly and appropriately, but they work. Everyone deserves the opportunity to pursue health and happiness. It is well-known that many doctors refuse to use these medications due to fear of abuse and diversion, and that is a travesty. Without ADF, honest and hard-working Americans are punished for the crimes of others by the under-treatment of their chronic pain. And that is why we bother with ADF opioids.
"There are three kinds of lies: lies, damned lies, and statistics."
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM